NZ717883A - Monoclonal antibodies against her2 - Google Patents

Monoclonal antibodies against her2

Info

Publication number
NZ717883A
NZ717883A NZ717883A NZ71788311A NZ717883A NZ 717883 A NZ717883 A NZ 717883A NZ 717883 A NZ717883 A NZ 717883A NZ 71788311 A NZ71788311 A NZ 71788311A NZ 717883 A NZ717883 A NZ 717883A
Authority
NZ
New Zealand
Prior art keywords
monoclonal antibodies
antibodies against
against her2
disclosed
her2
Prior art date
Application number
NZ717883A
Inventor
Bart De Goeij
Simone De Haij
Thilo Riedl
Rene Hoet
Ole Baadsgaard
Jan Van De Winkel
David Satijn
Paul Parren
Aran Frank Labrijn
Joyce Meesters
Janine Schuurman
Edward N Van Den Brink
Original Assignee
Genmab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/056388 external-priority patent/WO2011131746A2/en
Application filed by Genmab As filed Critical Genmab As
Publication of NZ717883A publication Critical patent/NZ717883A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed is a monoclonal antibody which binds human epidermal growth factor receptor 2 (HER2) comprising the CDRs of sequences as disclosed in the specification. Also disclose is the use of such antibodies for treating cancer.
NZ717883A 2010-05-27 2011-05-27 Monoclonal antibodies against her2 NZ717883A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34918010P 2010-05-27 2010-05-27
DKPA201000467 2010-05-27
PCT/EP2011/056388 WO2011131746A2 (en) 2010-04-20 2011-04-20 Heterodimeric antibody fc-containing proteins and methods for production thereof
DKPA201100312 2011-04-20
NZ62984911 2011-05-27

Publications (1)

Publication Number Publication Date
NZ717883A true NZ717883A (en) 2018-12-21

Family

ID=66477015

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ717883A NZ717883A (en) 2010-05-27 2011-05-27 Monoclonal antibodies against her2

Country Status (1)

Country Link
NZ (1) NZ717883A (en)

Similar Documents

Publication Publication Date Title
NZ604007A (en) Monoclonal antibodies against her2 epitope
NZ604003A (en) Monoclonal antibodies against her2
HK1253579A1 (en) Monoclonal anti-gt468 antibodies for treatment of cancer
IL238668A0 (en) Monoclonal antibodies against claudin-18 for treatment of cancer
MX2018010331A (en) Vegf/dll4 binding agents and uses thereof.
WO2012143524A3 (en) Bispecific antibodies against her2 and cd3
NZ601588A (en) Methods for treating breast cancer
NZ611785A (en) Anti-notch1 antibodies
NZ626610A (en) Antibodies that bind csf1r
SG194701A1 (en) Anti-cd40 antibodies and methods of use
HRP20180485T1 (en) Monoclonal antibodies for treatment of cancer
EP2579895A4 (en) Anti-vegf antibodies and uses thereof
MX347320B (en) Agr2 blocking antibody and use thereof.
MX2015002465A (en) Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1).
NZ717883A (en) Monoclonal antibodies against her2
NZ757754A (en) Antibodies that bind csf1r
NZ737925A (en) Monoclonal antibodies against c-met

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 27 MAY 2021 BY CPA GLOBAL

Effective date: 20190418

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2022 BY CPA GLOBAL

Effective date: 20210415

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2023 BY CPA GLOBAL

Effective date: 20220415

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 MAY 2024 BY CPA GLOBAL

Effective date: 20230413